Gehören Randstein Ausschreiben vka hamm Konkurs noch nie Talent
Efficacy and Safety of the Use of Nonâ•fiVitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibril
Verbund katholischer Altenhilfe e.V. – Der moderne Komplexanbieter in der Altenhilfe
VKA e.V.– The WINDBOX II Quad widely connected
JCM | Free Full-Text | Oral Anticoagulant Therapy—When Art Meets Science | HTML
Frontiers | Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification - International Journal of Cardiology
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation - Shields - 2015 - Journal of Internal Medicine - Wiley Online Library
Antithrombotic therapy after mitral valve repair: VKA or aspirin? | SpringerLink
Efficacy and safety outcomes in novel oral anticoagulants versus vitamin-K antagonist on post-TAVI patients: a meta-analysis | BMC Cardiovascular Disorders | Full Text
Anticoagulation in the cardiac patient: A concise review - Larson - 2019 - European Journal of Haematology - Wiley Online Library
A forest plot of network meta-analysis of interventions compared with... | Download Scientific Diagram
Triple Antithrombotic Therapy: Risky but Sometimes Necessary | Revista Española de Cardiología
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Dabigatran in real-world atrial fibrillation
JCM | Free Full-Text | Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of
Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance | Thrombosis Journal | Full Text
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
cluster rank incorporating risk estimate of major bleeding vs.... | Download Scientific Diagram
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation - The American Journal of Medicine
Verbund katholischer Altenhilfe e.V. – Der moderne Komplexanbieter in der Altenhilfe
Timo Halbe - Vorstand - VKA e.V. | XING
JCM | Free Full-Text | Oral Anticoagulant Therapy—When Art Meets Science | HTML
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: A meta-analysis - The Journal of Thoracic and Cardiovascular Surgery
Nipawin Hawks on Twitter: "Happy Belated Birthday to Chase Hamm! https://t.co/IhbJfGCOvD" / Twitter